Find News

Filter articles

Applied Filters

Showing 51 to 60 of 649 results

NHS partners with drugmakers to eliminate hep C


The National Health Service, the UK’s government-run health system, has partnered with Gilead Sciences, Merck Sharp and Dohme and AbbVie to help eliminate hepatitis C in England.

AstraZeneca partners on AI drug discovery collaboration


AstraZeneca has begun collaborating with UK-headquartered artificial intelligence company BenevolentAI to use AI and machine learning for the discovery and development of new treatments.

EU complains to WTO over Turkey’s pharma measures

EU, Turkey11-04-2019

The European Union has asked the World Trade Organization to initiate dispute consultations with Turkey over requirements imposed by the country on pharmaceutical products.

EPO president refers plant patentability decision for appeal


European Patent Office president António Campinos will refer a recent decision on the patentability of exclusively obtained by essentially biological processes to the office’s Enlarged Board of Appeal.

Eli Lilly defeat shows one size does not fit all in obviousness test: lawyers


The UK Supreme Court’s decision in Actavis v Eli Lilly confirms that a multi-factorial judgement should be used to determine whether an invention is obvious or not, lawyers have told WIPR.

Cancer Research UK forms immunotherapy alliance


Cancer Research UK has formed a multimillion-pound drug discovery alliance with fellow charity LifeArc and Japanese company Ono Pharmaceutical.

UK biotech R&D up 65% since 2016, says report


A “biotech boom” is underway in the UK, according to a new report from UK investment management firm Downing.

WHO to begin working on gene editing research registry


World Health Organization (WHO) experts have called for central registry on human genome editing research is needed, among a committee consensus that it would be irresponsible for any scientist to conduct gene-editing studies in people.

EU court backs medical device company over EUIPO


The EU General Court yesterday, March 20, annulled a European Union Intellectual Property Office (EUIPO) decision and handed a trademark victory to Spain-based Prim.

LSIPR webinar: No end in sight for CRISPR IP saga, says HGF

UK, US13-03-2019

Press releases in recent months that suggest the CRISPR IP saga is about to end are too optimistic and miss out many of the nuances of the current situation, according to Claire Irvine, partner at HGF.

Showing 51 to 60 of 649 results